СОВРЕМЕННЫЙ ПОДХОД В ЛЕЧЕНИИ ОСТРОГО ТРОМБОЗА ГЛУБОКИХ ВЕН ПРЕПАРАТОМ РИВАРОКСАБАН

СОВРЕМЕННЫЙ ПОДХОД В ЛЕЧЕНИИ ОСТРОГО ТРОМБОЗА ГЛУБОКИХ ВЕН ПРЕПАРАТОМ РИВАРОКСАБАН

Aim of prospective clinical study was to evaluate effectiveness, safety and convenience of treatment deep vein thrombosis with oral anticoagulant — Rivaroxaban from the 1st day of treatment. Study population: patients with verified acute deep vein thrombosis admitted to surgery clinic. 39 patients w...

Full description

Bibliographic Details
Main Authors:	Е. П. Кривощеко в, И. А. Мигунов
Format:	Article
Language:	Russian
Published:	SINAPS LLC 2015-06-01
Series:	Arhivʺ Vnutrennej Mediciny
Subjects:	deep vein thrombosis oral anticoagulant pulmonary embolism rivaroxaban
Online Access:	https://www.medarhive.ru/jour/article/view/408

Similar Items

СТРУКТУРА ФАКТОРОВ РИСКА ОСТРОГО ТРОМБОЗА ГЛУБОКИХ ВЕН НИЖНИХ КОНЕЧНОСТЕЙ
Published: (2012-07-01)

A study on the role of rivaroxaban in management of venous thromboembolism
by: Mohmed Abdalwahab, et al.
Published: (2015-10-01)

ПРИМЕНЕНИЕ ПЕРОРАЛЬНЫХ АНТИКОАГУЛЯНТОВ ПРИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ И НОВЫЕ ВОЗМОЖНОСТИ
by: Г. И. Сторожаков, et al.
Published: (2013-04-01)

Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
by: Abbas‎ Ghaysouri, et al.
Published: (2020-09-01)

Direct factor Xa inhibitor in the prevention of thromboembolism
by: Viktor Meretskyi, et al.
Published: (2019-01-01)

КОНСЕНСУС ЭКСПЕРТОВ ПО АНТИКОАГУЛЯНТНОЙ ТЕРАПИИ ВЕНОЗНОГО ТРОМБОЭМБОЛИЗМА В 2016 г. ЗНАЧЕНИЕ ПРОГРАММЫ ИССЛЕДОВАНИЙ РИВАРОКСАБАНА В ИЗМЕНЕНИИ ПОДХОДОВ К ЛЕЧЕНИЮ ТРОМБОЗА ГЛУБОКИХ ВЕН И ТРОМБОЭМБОЛИИ ЛЕГОЧНОЙ АРТЕРИИ
by: Editorial Board
Published: (2017-07-01)

Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations
by: Alexander Kaserer, et al.
Published: (2019-11-01)

Safe chest tube placement in a patient with tension pneumothorax receiving rivaroxaban therapy for non-valvular atrial fibrillation
by: Alessandro Cipriano, et al.
Published: (2020-06-01)

Thromboembolic recurrence frequency analysis in patients with deep vein thrombosis of lower extremities.
by: Sergyi Vasyliuk, et al.
Published: (2020-03-01)

Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practice
by: Beyer-Westendorf J, et al.
Published: (2017-01-01)

Oral and parenteral anticoagulants: New kids on the block
by: S Aditya
Published: (2012-01-01)

ВСТРЕЧАЕМОСТЬ МЕТАБОЛИЧЕСКОГО СИНДРОМА У БОЛЬНЫХ ОСТРЫМ ИДЕОПАТИЧЕСКИМ ТРОМБОЗОМ ГЛУБОКИХ ВЕН НИЖНИХ КОНЕЧНОСТЕЙ
Published: (2012-07-01)

EXTENDED THERAPY OF VENOUS THROMBOSIS BY ORAL ANTICOAGULANTS: FOCUS AT SAFETY
by: I. V. SCHASTLIVTSEV, et al.
Published: (2016-12-01)

HOW NEW APPROACHES TO THE TREATMENT OF PULMONARY EMBOLISM AFFECT THE OUTCOME OF THE DISEASE?
by: M. Y. Gilyarov, et al.
Published: (2017-12-01)

A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)
by: Hyeongsoo Kim, et al.
Published: (2020-01-01)

Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial
by: Paulus Kirchhof, et al.
Published: (2020-01-01)

Rivaroxaban in non valvular atrial fibrillation: subgroups analysis
by: Cesare Greco
Published: (2015-08-01)

Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice
by: N. M. Vorobyeva, et al.
Published: (2018-09-01)

Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation
by: S. G. Kanorskii
Published: (2016-09-01)

Antithrombotic Management and Long-Term Outcomes of Patients with Atrial Fibrillation. Insights from CRAFT Trial
by: Paweł Balsam, et al.
Published: (2021-04-01)

A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)
by: Tomas L. Lindahl, et al.
Published: (2017-07-01)

Isolated hemopericardium after initiation of rivaroxaban: Implications and potential mechanisms
by: Adwait Mehta, et al.
Published: (2019-01-01)

Recurrent Left Ventricular Thrombus Formation on Rivaroxaban Therapy in Cardiomyopathy and Liver Cirrhosis
by: Usman Ghani, MD, et al.
Published: (2020-08-01)

Современный подход к лечению периодонтита
Published: (2020-04-01)

Analysis of Anticoagulant Therapy in the Elderly Patients, in Clinical Practice of Family Medicine Centers in the Kyrgyz Republic
by: S. M. Mamatov, et al.
Published: (2021-05-01)

CHANGE OF ANTICOAGULANT EFFECT OF RIVAROXABAN DURING A DAY
by: I. V. Gel’Tser, et al.
Published: (2015-08-01)

Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial
by: Jodi V. Mones, et al.
Published: (2021-07-01)

Old and New anticoagulants: The beginning of a new era?
by: Fidel Cáceres Loriga, et al.
Published: (2011-01-01)

Patient-Reported Treatment Experience with Oral Rivaroxaban: Results from the Noninterventional XALIA Study of Deep-Vein Thrombosis
by: Stefan Cano, et al.
Published: (2018-04-01)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
by: Rupert Bauersachs, et al.
Published: (2020-05-01)

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
by: Jan Beyer-Westendorf, et al.
Published: (2019-04-01)

Periprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry
by: Raquel Ferrandis, et al.
Published: (2020-04-01)

Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis
by: Olivia S. Costa, et al.
Published: (2020-04-01)

Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers
by: Ramin Artang, et al.
Published: (2019-07-01)

Fatal pulmonary hemorrhage after taking anticoagulation medication
by: Samuel P. Hammar
Published: (2015-01-01)

Análise do grau de recanalização da trombose venosa profunda: estudo comparativo de pacientes tratados com varfarina versus rivaroxabana
by: Polyana Klomfass Piati, et al.

Spinal Cord Compression Secondary to a Spontaneous Spinal Haematoma in a Patient Newly Treated with Rivaroxaban
by: Javier Guerrero-Niño, et al.
Published: (2021-05-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)

The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
by: Maureane Hoffman, et al.
Published: (2018-12-01)

Assessment of novel oral anticoagulant use within a community teaching hospital
by: Sultan Alghadeer, et al.
Published: (2017-01-01)